The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.

Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical ...

Investing.com -- Edwards Lifesciences (NYSE:EW) stock rose 4.5% following the presentation of new data showing long-term benefits and valve performance of its SAPIEN 3 TAVR.

Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is collaborating with World ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...

Saint Alphonsus in Boise earned a three-star TAVR ranking from STS and ACC, placing it among the nation’s top heart programs ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Our guidelines no longer use risk as a standalone ...

Please provide your email address to receive an email when new articles are posted on . In patients with small aortic annuli requiring TAVR, self-expanding valves had better hemodynamic results than ...

Transcatheter aortic valve replacement (TAVR) is a procedure that can treat narrowing of the aortic valve in the heart. It involves an expandable replacement valve that helps improve blood flow. A ...